Accolade Valuation
| ACCDDelisted Stock | USD 7.02 0.00 0.00% |
At this time, the firm appears to be overvalued. Accolade shows a prevailing Real Value of $5.93 per share. The current price of the firm is $7.02. Our model approximates the value of Accolade from analyzing the firm fundamentals such as return on equity of -0.48, and Profit Margin of (0.40) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Accolade's price fluctuation is very steady at this time. Calculation of the real value of Accolade is based on 3 months time horizon. Increasing Accolade's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Accolade stock is determined by what a typical buyer is willing to pay for full or partial control of Accolade. Since Accolade is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Accolade Stock. However, Accolade's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.02 | Real 5.93 | Hype 7.02 | Naive 7.05 |
The real value of Accolade Stock, also known as its intrinsic value, is the underlying worth of Accolade Company, which is reflected in its stock price. It is based on Accolade's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Accolade's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Accolade helps investors to forecast how Accolade stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Accolade more accurately as focusing exclusively on Accolade's fundamentals will not take into account other important factors: Accolade Total Value Analysis
Accolade is presently forecasted to have valuation of 588 M with market capitalization of 575.59 M, debt of 241.65 M, and cash on hands of 330.63 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Accolade fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
588 M | 575.59 M | 241.65 M | 330.63 M |
Accolade Investor Information
About 88.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.84. Some equities with similar Price to Book (P/B) outperform the market in the long run. Accolade has Price/Earnings To Growth (PEG) ratio of 1.91. The entity recorded a loss per share of 2.28. The firm had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Accolade's historical financial statements, Accolade is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Accolade Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Accolade has an asset utilization ratio of 52.57 percent. This indicates that the Company is making $0.53 for each dollar of assets. An increasing asset utilization means that Accolade is more efficient with each dollar of assets it utilizes for everyday operations.Accolade Ownership Allocation
Accolade holds a total of 81.99 Million outstanding shares. The majority of Accolade outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Accolade to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Accolade. Please pay attention to any change in the institutional holdings of Accolade as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Accolade Profitability Analysis
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Accolade's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Accolade and how it compares across the competition.
About Accolade Valuation
The delisted stock valuation mechanism determines Accolade's current worth on a weekly basis. Our valuation model uses a comparative analysis of Accolade. We calculate exposure to Accolade's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Accolade's related companies.Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.
Accolade Growth Indicators
Investing in growth stocks can be very risky. If the company such as Accolade does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 74.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Accolade Stock
If you are still planning to invest in Accolade check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |